| ESBL | CPE | MDR-Acinetobacter | MDR-Pseudomonas | VRE | MRSA |
---|---|---|---|---|---|---|
Targeted screening (%) | ||||||
 Public (n = 102)a: | ||||||
  Institutional: | 82 (89%) | 77 (83%) | 37 (40%) | 36 (39%) | 38 (41%) | 93 (100%) |
  Only in certain units: | 0 | 0 | 1 (1%) | 2 (2%) | 4 (4%) | 0 |
  None: | 10 (11%) | 16 (17%) | 55 (59%) | 55 (59%) | 51 (55%) | 0 |
 Private (n = 78)b: | ||||||
  Institutional: | 36 (67%) | 38 (70%) | 23 (43%) | 18 (33%) | 27 (50%) | 52 (95%) |
  Only in certain units: | 4 (7%) | 4 (8%) | 2 (4%) | 8 (15%) | 3 (6%) | 3 (5%) |
  None: | 14 (26%) | 12 (22%) | 28 (53%) | 28 (52%) | 24 (44%) | 0 |